Literature DB >> 28693909

Synthesis and evaluation of 1-phenyl-1H-1,2,3-triazole-4-carboxylic acid derivatives as xanthine oxidase inhibitors.

Ting-Jian Zhang1, Qing-Xia Wu1, Song-Ye Li1, Lin Wang1, Qi Sun1, Yi Zhang1, Fan-Hao Meng2, Hua Gao3.   

Abstract

This study mainly focused on the modification of the X2 position in febuxostat analogs. A series of 1-phenyl-1H-1,2,3-triazole-4-carboxylic acid derivatives (1a-s) with an N atom occupying the X2 position was designed and synthesized. Evaluation of their inhibitory potency in vitro on xanthine oxidase indicated that these compounds exhibited micromolar level potencies, with IC50 values ranging from 0.21µM to 26.13μM. Among them, compound 1s (IC50=0.21μM) showed the most promising inhibitory effects and was 36-fold more potent than allopurinol, but was still 13-fold less potent than the lead compound Y-700, which meant that a polar atom fused at the X2 position could be unfavorable for potency. The Lineweaver-Burk plot revealed that compound 1s acted as a mixed-type xanthine oxidase inhibitor. Analysis of the structure-activity relationships demonstrated that a more lipophilic ether tail (e.g., meta-methoxybenzoxy) at the 4'-position could benefit the inhibitory potency. Molecular modeling provided a reasonable explanation for the structure-activity relationships observed in this study.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  1,2,3-Triazole; Hyperuricemia; Xanthine oxidase inhibitor

Mesh:

Substances:

Year:  2017        PMID: 28693909     DOI: 10.1016/j.bmcl.2017.06.059

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Synthesis and biological evaluation of thiazolidine-2-thione derivatives as novel xanthine oxidase inhibitors.

Authors:  Mu-Xuan Wang; Hong-Wei Qin; Chao Liu; Shen-Ming Lv; Jia-Shu Chen; Chun-Gu Wang; Ying-Ying Chen; Jia-Wei Wang; Jin-Yue Sun; Zhi-Xin Liao
Journal:  PLoS One       Date:  2022-05-18       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.